DBV Technologies (DBVT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $692.19M
Last updated: Nov 17, 2026 at 11:03 AM ET
Earnings
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 4.7% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 47.5, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about DBVT
News
DBVT Valuation
DBVT Profitability: Margins, ROIC and FCF
DBV Technologies (DBVT) has an operating margin of -5577.0% and a net margin of 0.0%. It posts -130.3% ROIC.
- Operating margin
- -5577.0%
- Net margin
- 0.0%
- ROIC
- -130.3%
- ROE
- -205.8%
- FCF yield
- -27.2%
DBV Technologies Competitors
The companies most similar to DBV Technologies (DBVT) include Vir Biotechnology, 4D Molecular Therapeutics and Valneva SE ADR.
Sector: Healthcare
Companies most similar to DBV TechnologiesDBVT Analyst Ratings
DBV Technologies (DBVT) has a Buy consensus from 7 analysts: 6 Buy or Strong Buy, 0 Hold and 1 Sell or Strong Sell.
- Consensus
- Buy
- Analysts
- 7
- Strong Buy
- 1
- Buy
- 5
- Hold
- 0
- Sell
- 1
- Strong Sell
- 0
DBVT Bull Case vs Bear Case
Bull case
- 85.7% of DBVT's analyst ratings are Buy or Strong Buy.
Bear case
- DBVT's quarterly revenue changed -42.9% year over year.
DBVT Earnings Call
The latest DBVT earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptUpdated Oct 30, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About DBVT
Does DBVT pay dividends?
DBV Technologies (DBVT) does not currently pay a regular dividend.
What is DBVT's market cap?
DBV Technologies (DBVT) has a market capitalization of $692.19M with a current stock price of $10.27.
How do analysts rate DBVT stock?
7 analysts cover DBV Technologies (DBVT): 1 rate it Strong Buy, 5 Buy, 0 Hold, 1 Sell and 0 Strong Sell, a consensus of Buy.
DBVT pages: Overview, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.